{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:09:48Z","timestamp":1780308588373,"version":"3.54.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10384-025-01308-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:39:17Z","timestamp":1764131957000},"page":"728-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of contamination in preservative-free multi-dose Brimonidine eye drops: a comparative study"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-2804","authenticated-orcid":false,"given":"Serap","family":"Karaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Sarmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Ali","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahide Busra","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabire Pelin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halit","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"8","key":"1308_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1508","volume":"6","author":"S Mughal","year":"2023","unstructured":"Mughal S, Sakina SK. Artificial tears: promising treatment or silent threat to public health? Health Sci Rep. 2023;6(8):e1508. https:\/\/doi.org\/10.1002\/hsr2.1508.","journal-title":"Health Sci Rep"},{"key":"1308_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00417-003-0777-7","volume":"241","author":"P Hamard","year":"2003","unstructured":"Hamard P, Blondin C, Debbasch C, Warnet JM, Baudouin C, Brignole F. In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefes Arch Clin Exp Ophthalmol. 2003;241:1037\u201343.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1308_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00061198-200204000-00007","volume":"11","author":"LJ Katz","year":"2002","unstructured":"Katz LJ. Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension. J Glaucoma. 2002;11(2):119\u201326. https:\/\/doi.org\/10.1097\/00061198-200204000-00007.","journal-title":"J Glaucoma"},{"key":"1308_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"N Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A, Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol. 2007;17:341\u20139.","journal-title":"Eur J Ophthalmol"},{"key":"1308_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2147\/OPTH.S17876","volume":"5","author":"A Hommer","year":"2011","unstructured":"Hommer A, Kimmich F. Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost. Clin Ophthalmol. 2011;5:623\u201331. https:\/\/doi.org\/10.2147\/OPTH.S17876.","journal-title":"Clin Ophthalmol"},{"key":"1308_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/meajo.MEAJO_308_16","volume":"24","author":"A Tsegaw","year":"2017","unstructured":"Tsegaw A, Tsegaw A, Abula T, Assefa Y. Bacterial contamination of multi-dose eye drops at ophthalmology department, university of Gondar, Northwest Ethiopia. Middle East Afr J Ophthalmol. 2017;24:81\u20136.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"1308_CR7","first-page":"36035","volume":"45","author":"A Campolo","year":"2022","unstructured":"Campolo A, Crary M, Shannon P. A review of the containers available for multi-dose preservative-free eye drops. Biomed J Sci Tech Res. 2022;45:36035\u201344.","journal-title":"Biomed J Sci Tech Res"},{"issue":"8","key":"1308_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/10807683251363844","volume":"41","author":"A Sarmis","year":"2025","unstructured":"Sarmis A, Yilmaz OF, Mutlu MA, Karaca S, Turan D, Oguz H. Assessment of bacterial and fungal contamination in preservative-free multi-dose cyclosporine eye drops. J Ocul Pharmacol Ther. 2025;41(8):455\u201362. https:\/\/doi.org\/10.1177\/10807683251363844.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1308_CR9","doi-asserted-by":"publisher","first-page":"20364","DOI":"10.1038\/s41598-021-99892-8","volume":"11","author":"T Daehn","year":"2021","unstructured":"Daehn T, Schneider A, Knobloch J, Hellwinkel OJC, Spitzer MS, Kromer R. Contamination of multi-dose eyedrops in the intra and perioperative context. Sci Rep. 2021;11:20364.","journal-title":"Sci Rep"},{"key":"1308_CR10","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.7.7","volume":"9","author":"AX da Costa","year":"2020","unstructured":"da Costa AX, Zorat Yu MC, de Cristovam PC, Freitas D, La Monica LC, Dos Santos VR, et al. Microbial cross-contamination in multidose eyedrops: the impact of instillation angle and bottle geometry. Transl Vis Sci Technol. 2020;9:7.","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"1308_CR11","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/bjo.2007.116897","volume":"91","author":"MM Nentwich","year":"2007","unstructured":"Nentwich MM, Kollmann KH, Meshack J, Ilako DR, Schaller UC. Microbial contamination of multi-use ophthalmic solutions in Kenya. Br J Ophthalmol. 2007;91(10):1265\u20138. https:\/\/doi.org\/10.1136\/bjo.2007.116897.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"1308_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000583","volume":"94","author":"B Teuchner","year":"2015","unstructured":"Teuchner B, Wagner J, Bechrakis NE, Orth-Holler D, Nagl M. Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital. Medicine (Baltimore). 2015;94(8):e583. https:\/\/doi.org\/10.1097\/MD.0000000000000583.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1308_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/eye.2013.187","volume":"27","author":"AJ Tatham","year":"2013","unstructured":"Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013;27(11):1293\u20138. https:\/\/doi.org\/10.1038\/eye.2013.187.","journal-title":"Eye (Lond)"},{"key":"1308_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.optom.2016.11.002","volume":"10","author":"M Safarzadeh","year":"2017","unstructured":"Safarzadeh M, Azizzadeh P, Akbarshahi P. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops. J Optom. 2017;10:258\u201364.","journal-title":"J Optom"},{"key":"1308_CR15","first-page":"2131","volume":"7","author":"LM Rosin","year":"2013","unstructured":"Rosin LM, Bell NP. Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clin Ophthalmol. 2013;7:2131\u20135.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"1308_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36(2):361\u20138. https:\/\/doi.org\/10.1038\/s41433-021-01668-x.","journal-title":"Eye (Lond)"},{"issue":"4","key":"1308_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.sjopt.2011.08.004","volume":"25","author":"A Bagnis","year":"2011","unstructured":"Bagnis A, Papadia M, Scotto R, Traverso CE. Antiglaucoma drugs: the role of preservative-free formulations. Saudi J Ophthalmol. 2011;25(4):389\u201394. https:\/\/doi.org\/10.1016\/j.sjopt.2011.08.004.","journal-title":"Saudi J Ophthalmol"},{"key":"1308_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","volume":"23","author":"RJ Noecker","year":"2004","unstructured":"Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490\u20136.","journal-title":"Cornea"},{"key":"1308_CR19","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00417-023-05977-7","volume":"261","author":"OF Yilmaz","year":"2023","unstructured":"Yilmaz OF, Sarmis A, Mutlu MA, Ersoy EE, Askarova U, Oguz H. Bacterial contamination of multi-use antibiotic steroid eye ointments and drops. Graefes Arch Clin Exp Ophthalmol. 2023;261:1691\u2013700.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"1308_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.102064","volume":"46","author":"OF Yilmaz","year":"2023","unstructured":"Yilmaz OF, Sarmis A, Mutlu MA, Sahin ZB, Kaya SP, Oguz H. Bacterial contamination of multi-use tear drops, gels, and ointments. Cont Lens Anterior Eye. 2023;46(6):102064. https:\/\/doi.org\/10.1016\/j.clae.2023.102064.","journal-title":"Cont Lens Anterior Eye"},{"key":"1308_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.5935\/0004-2749.20210070","volume":"84","author":"CM Costa","year":"2021","unstructured":"Costa CM, Esp\u00f3sito KP, Brand\u00e3o Flor\u00eancio VM, Aquino PRL, Firmo EF, do Amaral Costa IM, et al. Evaluation of microbial contamination in multi-dose fluorescein eyedrops in a reference eye center. Arq Bras Oftalmol. 2021;84:449\u201353 ((in Portugese)).","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"1308_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/08164622.2024.2374867","volume":"108","author":"A Sarmis","year":"2025","unstructured":"Sarmis A, Yilmaz OF, Mutlu MA, Kocoglu ME. Micrococcus-induced keratitis in a patient wearing contact lenses. Clin Exp Optom. 2025;108(2):211\u20133. https:\/\/doi.org\/10.1080\/08164622.2024.2374867.","journal-title":"Clin Exp Optom"},{"issue":"1","key":"1308_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/ICB.0000000000000532","volume":"13","author":"BD Wilson","year":"2019","unstructured":"Wilson BD, Relhan N, Miller D, Flynn HW Jr. Gram-negative bacteria from patients with endophthalmitis: distribution of isolates and antimicrobial susceptibilities. Retin Cases Brief Rep. 2019;13(1):54\u20136. https:\/\/doi.org\/10.1097\/ICB.0000000000000532.","journal-title":"Retin Cases Brief Rep"},{"key":"1308_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archophthalmol.2009.96","volume":"127","author":"JL Stone","year":"2009","unstructured":"Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol. 2009;127:732\u20136.","journal-title":"Arch Ophthalmol"},{"key":"1308_CR25","first-page":"12","volume":"29","author":"R Jalali","year":"2004","unstructured":"Jalali R, Zinolabedini F, Moradi M, Dibazar N. Bacterial contamination rate of eyedrops: comparison of a hospital and a private outpatient center in Kermanshah, Iran. Insight (Am Soc Ophthalmic Reg Nurses). 2004;29:12\u20134.","journal-title":"Insight (Am Soc Ophthalmic Reg Nurses)"},{"issue":"11","key":"1308_CR26","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1185\/03007995.2013.833898","volume":"29","author":"GF Schwartz","year":"2013","unstructured":"Schwartz GF, Hollander DA, Williams JM. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Curr Med Res Opin. 2013;29(11):1515\u201322. https:\/\/doi.org\/10.1185\/03007995.2013.833898.","journal-title":"Curr Med Res Opin"},{"key":"1308_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ogla.2020.08.003","volume":"4","author":"KJ Schneider","year":"2021","unstructured":"Schneider KJ, Hollenhorst CN, Vallicevic AN, Niziol LM, Heisler M, Musch DC, et al. Impact of the support, educate, empower personalized glaucoma coaching program pilot study on eye drop instillation technique and self-efficacy. Ophthalmol Glaucoma. 2021;4:42\u201350.","journal-title":"Ophthalmol Glaucoma"},{"key":"1308_CR28","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/pathogens11050592","volume":"11","author":"JH Lee","year":"2022","unstructured":"Lee JH, Kang MJ, Sim HE, Hwang JH. Microbial contamination of preservative-free artificial tears based on instillation techniques. Pathogens. 2022;11:592.","journal-title":"Pathogens"},{"issue":"9","key":"1308_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204363","volume":"13","author":"T Naito","year":"2018","unstructured":"Naito T, Yoshikawa K, Namiguchi K, Mizoue S, Shiraishi A, Ichikawa Y, et al. Comparison of success rates in eye drop instillation between sitting position and supine position. PLoS ONE. 2018;13(9):e0204363. https:\/\/doi.org\/10.1371\/journal.pone.0204363.","journal-title":"PLoS ONE"},{"key":"1308_CR30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/OPTH.S126042","volume":"11","author":"FJ Munoz Negrete","year":"2017","unstructured":"Munoz Negrete FJ, Lemij HG, Erb C. Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction. Clin Ophthalmol. 2017;11:557\u201366.","journal-title":"Clin Ophthalmol"},{"key":"1308_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharma.2010.10.001","volume":"69","author":"P Gabisson","year":"2011","unstructured":"Gabisson P, Briat B, Le Foll J, Conan S, Bale-Le Bescond F, Talmud M, et al. Handiness and acceptability of the new Abak bottle in chronically treated patients: a cross-sectional, retrospective and multicentre study. Ann Pharm Fr. 2011;69:22\u20139 ((in French)).","journal-title":"Ann Pharm Fr"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01308-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01308-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01308-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:54:58Z","timestamp":1780307698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01308-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01308-x","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. Karaca, None; A. Sarmis, None; O. F. Yilmaz, None; M. A. Mutlu, None; Z. B. Sahin, None; S. P. Kaya, None; H. Oguz, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}